Open for inclusion

A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory DLBCL

Cancer type: Lymphoma

Phase: II

Principal Investigator: Holte Harald

Country: NO

Keywords: Norway, Oslo, Adults, CTL019 and diffuse large B-cell lymphoma (DLBCL)

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02445248?term=CTL019C2201&rank=1